Scholar Rock Holding Stock Jumps 293% After Spinal Drug Trial
Scholar Rock(SRRK.US) Officer Sells US$5.48 Million in Common Stock
Scholar Rock (SRRK.US) stock price soared 335%, with candidate SMA drug successfully passing the third stage of trials.
Scholar Rock Holding Corp.'s stock price surged 335% in Monday's trading session.
Scholar Rock(SRRK.US) Director Sells US$34.39 Million in Common Stock
Form 144 | Scholar Rock(SRRK.US) Director Proposes to Sell 34.39 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 7, $Scholar Rock(SRRK.US)$ Director AKKARAJU SRINIVAS intends to sell 1.18 million shares of its common stock on Oct 7, with a total market value of approximately $34.39
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating, Announces Target Price $36
Health Care Losses Limited By Defensive Bias - Health Care Roundup
After-hours Movers: PENN Entertainment, Scholar Rock, and More
Scholar Rock Announces $275M Common Stock Offering
Express News | Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Express News | Scholar Rock Holding Corp Files for Mixed Shelf; Size Not Disclosed-SEC Filing
Market Falls Monday to Start the First Week of Q3 Earnings | Wall Street Today
Scholar Rock SRRK Phase 3 Success; Oncolytics ONCY Accelerated Pathway
Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge
How Is The Market Feeling About Scholar Rock Holding?
Trending Stocks Today | Scholar Rock Shoots up 321.02%
Top Midday Gainers
RBC Says Scholar Rock 'Win' in SMA Has Favorable Biohaven Implications
Scholar Rock Holding Is Maintained at Outperform by Wedbush
Scholar Rock Holding Analyst Ratings